The Impact of Nirmatrelvir-Ritonavir in Reducing Hospitalizations Among High-Risk Patients With SARS-CoV-2 During the Omicron Predominant Era.

Mohanad M Al-Obaidi,Ahmet B Gungor,Sangeetha Murugapandian,Bijin Thajudeen,Iyad Mansour,Ryan C Wong,Bekir Tanriover,Tirdad T Zangeneh

The American journal of medicine（2023）

引用 1|浏览14

暂无评分

摘要

We report a significant benefit with the use of NR in reducing hospitalizations among various high-risk COVID-19 groups during the Omicron BA.5 predominant period.

查看译文

关键词

COVID-19,Nirmatrelvir-ritonavir,Omicron variant

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要